Interní Med. 2001; 3(4): 175-177

Primární plicní hypertenze v roce 2001

MUDr. Jana Gandalovičová
II. interní klinika kardiologie a angiologie 1. LF UK a VFN, Praha

Published: December 31, 2001  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gandalovičová J. Primární plicní hypertenze v roce 2001. Interní Med. 2001;3(4):175-177.

Z materiálů prezentovaných během přednáškového cyklu Controversies in Cardiology při Cardiovascular Institute, The Mount Sinai Medical Center, NYU.

Download citation

References

  1. Hatano S et al.: World Health Organization 1975 primary pulmonary hypertension: report of committee. Geneva, Switzerland.
  2. Nichols CW, Koller DL, et al. Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31-32. Nat Genet 1997, 15: 277-80. Go to original source... Go to PubMed...
  3. Archer S, Rich S. Primary Pulmonary Hypertension: A Vascular Biology and Translation research, ,Work in Progress". Circulation 2000, 102:2781-2791. Go to original source... Go to PubMed...
  4. Giaid A, Saleh D. Reduced Expression of Endothelial Nitric Oxide Synthase in the Lungs of Patients with pulmonary Hypertension. NEJM 1995, 333: 251-253. Go to original source... Go to PubMed...
  5. Giaid A. Nitric Oxide and Endothelin-1 in Pulmonary Hypertension. Chest 1998, 114: 208-212. Go to original source... Go to PubMed...
  6. Channick RN et al. Bosentan, a dual endothelin receptor antagonist, improves exercise capacity and hemodynamics in patients with pulmonary arterial hypertension: results of a double blind, randomized, placebo controlled trial. Circulation 2000 Oct, 102 (18), abstract 476.
  7. Welsh CH, et al.Coagulation and fibrinolytic profiles in patients with severe pulmonary hypertension. Chest 1996, 110:710-717. Go to original source... Go to PubMed...
  8. Peacock AJ. Primary pulmonary hypertension. Thorax 1999, 54: 1107. Go to original source... Go to PubMed...
  9. Abenhaim L, et al. The International Primary Pulmonary Hypertension Study Group. NEJM 1996, 335: 609-616. Go to original source... Go to PubMed...
  10. Mandell MS, Groves BM. Pulmonary hypertension in chronic liver disease. Clin Chest Med 1996, 17: 17. Go to original source... Go to PubMed...
  11. Executive Summary from the World Symposium on Primary Pulmonary Hypertension 1998, co-sponsored by the World Health Organization and edited by Stuart Rich, MD.
  12. Barst RJ, Rich S, et al. A comparison of continuos intravenous epoprostenol with conventional therapy for primary pulmonary hypertenzion. NEJM 1996, 334: 296-301. Go to original source... Go to PubMed...
  13. Harringer W, et al. Lung transplantation - 10 year experience. Eur J Cardiothorac Surg 1999 Nov, 16(5): 546-54. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.